71406-78-5 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 4-amino-2-chloropyrimidine-5-carboxylate is used as an intermediate in the production of pharmaceuticals, particularly in the synthesis of antiviral and anticancer drugs. Its unique structure allows for the development of compounds with potential therapeutic effects against viral infections and cancer.
Used in Antiviral Drug Development:
In the field of antiviral drug development, ethyl 4-amino-2-chloropyrimidine-5-carboxylate serves as a key intermediate for the synthesis of compounds that can inhibit viral replication and reduce the severity of viral infections. Its ability to bind to specific viral targets makes it a valuable component in the creation of effective antiviral medications.
Used in Anticancer Drug Development:
Ethyl 4-amino-2-chloropyrimidine-5-carboxylate is also utilized in the development of anticancer drugs. Its potential to interact with cellular targets and disrupt cancer cell processes makes it a promising candidate for the synthesis of compounds that can inhibit tumor growth and proliferation.
Used in Research and Development:
Due to its potential applications in pharmaceuticals, ethyl 4-amino-2-chloropyrimidine-5-carboxylate is of interest to researchers and pharmaceutical companies for further development and study. Its unique properties and potential for biological activity make it a valuable compound for exploring new therapeutic approaches and advancing the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 71406-78-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,0 and 6 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 71406-78:
(7*7)+(6*1)+(5*4)+(4*0)+(3*6)+(2*7)+(1*8)=115
115 % 10 = 5
So 71406-78-5 is a valid CAS Registry Number.
71406-78-5Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00667-00669, (2013/03/26)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
